US 11,730,429 B2
Displays for a medical device
Wesley Scott Harper, Alameda, CA (US); Annie C. Tan, Redwood City, CA (US); Timothy Christian Dunn, San Francisco, CA (US); Mark Kent Sloan, Redwood City, CA (US); Kenneth J. Doniger, Menlo Park, CA (US); Michael Love, Pleasanton, CA (US); Phillip Yee, San Francisco, CA (US); Gary Alan Hayter, Oakland, CA (US); R. Curtis Jennewine, Portland, OR (US); Glenn Howard Berman, Alameda, CA (US); and Erich Yen, Oakland, CA (US)
Assigned to ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed by ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed on Jan. 20, 2022, as Appl. No. 17/580,593.
Application 17/580,593 is a continuation of application No. 17/107,097, filed on Nov. 30, 2020, granted, now 11,241,175.
Application 17/107,097 is a continuation of application No. 17/067,443, filed on Oct. 9, 2020, granted, now 10,918,342, issued on Feb. 16, 2021.
Application 17/067,443 is a continuation of application No. 16/902,111, filed on Jun. 15, 2020, granted, now 10,881,355, issued on Jan. 5, 2021.
Application 16/902,111 is a continuation of application No. 16/664,083, filed on Oct. 25, 2019, granted, now 10,772,572, issued on Sep. 15, 2020.
Application 16/664,083 is a continuation of application No. 16/181,081, filed on Nov. 5, 2018, granted, now 10,456,091, issued on Oct. 29, 2019.
Application 16/181,081 is a continuation of application No. 15/808,918, filed on Nov. 10, 2017, granted, now 10,123,752, issued on Nov. 13, 2018.
Application 15/808,918 is a continuation of application No. 15/377,989, filed on Dec. 13, 2016, granted, now 9,814,416, issued on Nov. 14, 2017.
Application 15/377,989 is a continuation of application No. 14/938,840, filed on Nov. 11, 2015, granted, now 9,549,694, issued on Jan. 24, 2017.
Application 14/938,840 is a continuation of application No. 14/457,066, filed on Aug. 11, 2014, granted, now 9,186,113, issued on Nov. 17, 2015.
Application 14/457,066 is a continuation of application No. 13/970,556, filed on Aug. 19, 2013, granted, now 8,816,862, issued on Aug. 26, 2014.
Application 13/970,556 is a continuation of application No. 12/871,901, filed on Aug. 30, 2010, granted, now 8,514,086, issued on Aug. 20, 2013.
Claims priority of provisional application 61/297,625, filed on Jan. 22, 2010.
Claims priority of provisional application 61/247,541, filed on Sep. 30, 2009.
Claims priority of provisional application 61/238,672, filed on Aug. 31, 2009.
Claims priority of provisional application 61/238,657, filed on Aug. 31, 2009.
Prior Publication US 2022/0142524 A1, May 12, 2022
Int. Cl. A61B 5/00 (2006.01); A61B 5/145 (2006.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); G01N 33/487 (2006.01); G16Z 99/00 (2019.01)
CPC A61B 5/7445 (2013.01) [A61B 5/14 (2013.01); A61B 5/145 (2013.01); A61B 5/14532 (2013.01); A61B 5/7275 (2013.01); A61B 5/7282 (2013.01); A61B 5/743 (2013.01); A61B 5/746 (2013.01); A61B 5/748 (2013.01); A61B 5/7425 (2013.01); A61B 5/7435 (2013.01); A61B 2560/045 (2013.01); A61B 2562/0295 (2013.01); G01N 33/48785 (2013.01); G01N 33/48792 (2013.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); G16Z 99/00 (2019.02)] 19 Claims
OG exemplary drawing
 
1. A glucose monitoring system comprising:
a glucose sensor configured to be positioned at least in part in contact with interstitial fluid in a body of a user;
a transmitter unit configured to be coupled to the glucose sensor and process data indicative of a plurality of monitored glucose levels from the glucose sensor; and
a receiver unit comprising a processor and a user interface having a display, wherein the receiver unit is configured to receive the processed data from the transmitter unit, wherein the display is configured to render a plurality of display screens, including at least a home screen, a first alert screen, and a second alert screen, wherein the home screen is divided into a plurality of simultaneously displayed panels, wherein a first panel of the plurality of panels is configured to display the plurality of monitored glucose levels, wherein a second panel of the plurality of panels is configured to simultaneously display a current glucose level and a glucose trend indicator, and wherein a third panel of the plurality of panels is configured to display status information of a plurality of components of the glucose monitoring system;
wherein the display is further configured to:
render the first alert screen on the display when a first alarm condition is detected, wherein the first alarm condition corresponds to a projected low glucose condition, the first alert screen having information corresponding to the first alarm condition, and
to affect a further output of the glucose monitoring system corresponding to the first alarm condition in response to user actuation of a portion of the display;
and wherein the processor is configured to:
cause the display to render the plurality of display screens;
determine whether the first alarm condition has been resolved; and
display the second alert screen in place of the displayed first alert screen when a second alarm condition is detected prior to the first alarm condition being resolved, wherein the second alarm condition corresponds to a low glucose condition, and wherein the second alarm condition has a higher priority than the first alarm condition.